146
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Which substances pose the greatest risk of substance use disorder after controlling for polysubstance use?

, &
Received 20 Jul 2023, Accepted 28 Nov 2023, Published online: 16 Dec 2023

References

  • American Psychiatric Association. 2013. Diagnostic and statistical manual of mental disorders: DSM-5. Arlington, VA: american Psychiatric Association.
  • Anthony JC, Warner LA, Kessler RC. 1994. Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants: basic findings from the national comorbidity survey. Exp Clin Psychopharmacol. 2(3):244–268. doi:10.1037/1064-1297.2.3.244.
  • Bailey AJ, Farmer EJ, Finn PR. 2019. Patterns of polysubstance use and simultaneous co-use in high risk young adults. Drug Alcohol Depend. 205:107656. doi:10.1016/j.drugalcdep.2019.107656.
  • Center for Behavioral Health Statistics and Quality. 2022a. 2021 National Survey on Drug Use and Health Public Use File Codebook. Substance Abuse and Mental Health Services Administration: Rockville, MD.
  • Center for Behavioral Health Statistics and Quality. 2022b.). 2021 National Survey on Drug Use and Health (NSDUH): Methodological summary and definitions. Substance Abuse and Mental Health Services Administration. https://www.samhsa.gov/data/report/2021-methodological-summary-and-definition.
  • Compton WM, Valentino RJ, DuPont RL. 2020. Polysubstance use in the U.S. opioid crisis. Mol Psychiatry. 26(1):41–50. doi:10.1038/s41380-020-00949-3.
  • Crummy EA, O'Neal TJ, Baskin BM, Ferguson SM., 2020. One is not enough: understanding and modeling polysubstance use. Front Neurosci. 14:569. doi:10.3389/fnins.2020.00569.
  • Gable RS. 2004. Comparison of acute lethal toxicity of commonly abused psychoactive substances. Addiction. 99(6):686–696. doi:10.1111/j.1360-0443.2004.00744.x.
  • Hedegaard H, Miniño AM, Warner M. 2020. Drug overdose deaths in the United States, 1999–2018. NCHS Data Brief, No. 356. Hyattsville, MD: National Center for Health Statistics.
  • Hyman SE, Malenka RC, Nestler EJ. 2006. Neural mechanisms of addiction: the role of reward-related learning and memory. Annu Rev Neurosci. 29(1):565–598. doi:10.1146/annurev.neuro.29.051605.113009.
  • Lumley T. 2023. Survey: analysis of complex survey samples. R Package Version 4.2. https://rdocumentation.org/packages/survey/versions/4.2-1
  • McCabe SE, West BT, Jutkiewicz EM, Boyd CJ. 2017. Multiple DSM-5 substance use disorders: a national study of U.S. adults. Hum Psychopharmacol. 32(5):e2625.
  • Nutt DJ, King LA, Phillips LD, Independent Scientific Committee on Drugs. 2010. Drug harms in the UK: a multicriteria decision analysis. Lancet. 376(9752):1558–1565. doi:10.1016/S0140-6736(10)61462-6.
  • Palamar JJ, Kiang MV, Halkitis PN. 2012. Predictors of stigmatization towards use of various illicit drugs among emerging adults. J Psychoactive Drugs. 44(3):243–251. doi:10.1080/02791072.2012.703510.
  • Paradis C, Butt P, Shield K, Poole N, Wells S, Naimi T, Sherk A, the Low-Risk Alcohol Drinking Guidelines Scientific Expert Panel. 2023. & Canada’s guidance on alcohol and health: final report. Ottawa, Ontario: Canadian Centre on Substance Use and Addiction. doi:10.1111/add.16316.
  • Reuter P, Caulkins JP, Midgette G. 2021. Heroin cannot be measured adequately with ′general population survey. Addiction. 116(10):2600–2609. doi:10.1111/add.15458.
  • Rotermann M. 2020. What has changed since cannabis was legalized? Health Rep. 31(2):11–22.
  • Substance Abuse and Mental Health Services Administration [SAMHSA]. 2022. Key substance use and mental health indicators in the United States: results from the 2021 National Survey on Drug Use and Health [Internet]. Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. Report No.: HHS Publication No. PEP21-07-01-003, NSDUH Series H-56. Available from: https://www.samhsa.gov/data/.
  • Wagner FA, Anthony JC. 2002. From first drug use to drug dependence: developmental periods of risk for dependence upon marijuana, cocaine, and alcohol. Neuropsychopharmacology. 26(4):479–488. doi:10.1016/S0893-133X(01)00367-0.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.